Emerging histopathological prognostic biomarkers in hepatocellular carcinomas

Conclusion Identification of novel, effective biomarkers for the diagnosis and prognosis of HCC is critical for the improvement of companion diagnostics in personalized oncology therapies for HCC. The molecules described in this review are attractive candidates for future HCC biomarkers to be used in clinical oncology practice.
Source: Personalized Medicine Universe - Category: Drugs & Pharmacology Source Type: research